Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Public ClinicalTrials.gov record NCT00913133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center Trial of Desirudin for the Prophylaxis of Thrombosis: an Alternative to Heparin-Based Anticoagulation (DESIR-ABLE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this trial is to demonstrate the clinical utility of fixed-dose SC Desirudin for the prophylaxis of thrombosis as an alternative to heparin-based anticoagulation.
Study identification
- NCT ID
- NCT00913133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 516 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2010
- Primary completion
- May 31, 2011
- Completion
- May 31, 2011
- Last update posted
- Jan 9, 2013
2010 – 2011
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado Health Science Center | Aurora | Colorado | 80045 | — |
| University of South Florida, Tampa General Hospital | Tampa | Florida | 33606 | — |
| Saint Joseph's Research Institute | Atlanta | Georgia | 30342 | — |
| Southeastern Center for Clinical Trials | Decatur | Georgia | 30033 | — |
| Provena St. Joseph's Medical Center | Joliet | Illinois | 60435 | — |
| Illinois Lung and Critical Care Institute | Peoria | Illinois | 61606 | — |
| St. John's Mercy Medical Center | St Louis | Missouri | 63141 | — |
| Overlook Hospital | Summit | New Jersey | 07901 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794-8191 | — |
| Forsyth Regional Medical Center | Winston-Salem | North Carolina | 27103 | — |
| Forsyth Regional Medical Center | Winston-Salem | North Carolina | 55902 | — |
| The Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19102-1192 | — |
| Research Concepts, Memorial Hermann Healthcare System | Houston | Texas | 77024 | — |
| Carilion Roanoke Memorial Hospital | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00913133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2013 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00913133 live on ClinicalTrials.gov.